1spatial Share Discussion Threads

[meenashah] 30/3/2007 08:08

looks like market did not like the results. but you expect losses for such a company anyway and as long as they can fund themselves through collaborations and licensing that is fine. also the new equity issue is fine - did no harm in Nov!!

[share_shark] 30/3/2007 07:49

Second that Mike.

[mike111d] 30/3/2007 07:46

So results out as expected and it is sounding like they have a real sense of purpose going forwards, which I very much like. Good luck all.

[barefoot1] 30/3/2007 07:25

Current price on mon.am....99p..will it open at that ;o)

[texicon] 30/3/2007 07:13

Silence therapeutics-nice name.Very positive outlook.

[barefoot1] 30/3/2007 07:04

SR Pharma Preliminary Final Results

SR PHARMA PLC

('SR Pharma', 'the Group' or 'the Company')

PRELIMINARY RESULTS for the year ended 31 December 2006

London, UK, 30 March 2007 - SR Pharma plc (London LSE: SPA), Europe's leading RNAi therapeutics company, today announces its unaudited preliminary results for the year ended 31 December 2006.

2006 Highlights

* SR Pharma positioned as a world leader in RNAi therapeutics * SR Pharma generates revenues as a result of a sub-licensing deal for one of its AtuRNAi molecules between Quark Biotech Inc and Pfizer Inc. Total revenues to SR Pharma from this deal could amount to US$95m plus royalties * Pre-clinical results published on SR Pharma's lead internal development AtuRNAi molecule in pancreatic cancer * Positive pre-clinical data published supporting the systemic application of SR Pharma's siRNA-lipoplex (AtuPLEX) technology in oncology applications Post Period End Highlights

* January 2007 - The European Patent Office grants our core chemistry patent for AtuRNAi providing SR Pharma with freedom to develop novel RNAi therapeutics * February 2007 - Quark Biotech and Pfizer begin Phase I trials with one of SR Pharma's AtuRNAi molecules in Age-related Macular Degeneration (AMD) * March 2007 - Quark granted IND prior to commencing Phase I trials with a second AtuRNAi molecule for acute kidney injury Group Financials

* Revenues increased by 282% to £1.95m (2005: £0.5m) * R&D spend up by 92% to £3.19m (2005: £1.66m) * Cash Position of £8.82m at the period end (31 Dec. 2005: £9.09m) Change of Name

A new corporate identity proposed to reflect the Company's core focus and position in the RNAi sector - Silence Therapeutics

Iain Ross, Executive Chairman, commented:

"2006 was an exciting year for the Group during which it made a great deal of progress and generated significant returns for the shareholders.

In 2007 we expect to report further significant events, which will reinforce the Group's ability to generate value from its world leading RNAi expertise.

During 2007 the Group is forecasting a significant increase in R&D and infrastructure costs as our lead siRNA molecules move into the clinic later in the year and the Group establishes operations in the US. These increased costs are expected to be funded through a continuation of the collaboration and licence strategy with major pharmaceutical and biotechnology companies, and the Group is in discussions with a number of potential third party collaborators.

Over the last twelve months, your board, executive management team and staff worked with commitment and resolve to create a business with real substance. It has been a great pleasure to work with such a dedicated group of people and I would like to thank them all for their support. Also I would especially like to thank the shareholders who have stuck with us throughout the year and I believe with hard work and a little good fortune we will be able to further enhance shareholder value over the coming twelve months."

[barefoot1] 29/3/2007 23:53

£1 would doo me...;o)

[texicon] 29/3/2007 23:52

90p here we come!

[geoffmanana] 29/3/2007 23:49

If you do know something Houseprices I agree with Buzzzzzzz be careful.

I think these babies are going to fly tomorrow!!!!!!!!!!!!!!

[texicon] 29/3/2007 22:35

Ab,ever get the feeling you're talking to yourself!Lol!:-)

[buzzzzzzzz] 29/3/2007 17:53

3frog
Spreadex picked them up at 77.5p around 3.30 yesterday.

Well it looks like results out tomorrow morning.

I will be interested to see if there is a statement regarding the future prospects of SPA.

Remember we are only halfway to the brokers note target of £1.50.

I shall continue to hold.

Houseprices be careful!

[snoppity] 29/3/2007 16:29

A good one I hope!

[houseprices] 29/3/2007 16:25

Think you will find a notice being published with the results.

[houseprices] 29/3/2007 16:23

Yes, and staying there for a bit

[alwaysbanking] 29/3/2007 15:33

Thanks for that Houseprices, r u in.

[houseprices] 29/3/2007 15:06

Results will be published tomorrow morning after all. Best of luck everyone!

[3frog] 29/3/2007 11:43

Thanks digger, web-site now in my bookmarks list.

Welcome houseprices.

[houseprices] 29/3/2007 11:40

Always, i'm not a ramper, just a recent holder at the 72p level. Got this from a very good source a few weeks ago and Im sticking with it. I can't say anymore about what else will be stated, but it is bullish. I,m confident of £1 within the next 4 weeks. We'll see!

[digger27] 29/3/2007 11:38

Certainly hope so 3frog.
So far as the results are concerned I always look at ShareCast "week ahead" as they are usually reliable. Nothing shown for this week.

[alwaysbanking] 29/3/2007 11:30

Houseprices, is that fact if so where from - if not then another ramper and new name to the board.

from the related thread Charts etc

AlwaysBanking - 16 Mar'07 - 09:24 - 146 of 148 edit


Not a bad call yesterday, today is a different day. The weak sellers will be those that bought on the rumour at around 80 - 82.5 (getting out - expiry of T deadlines) once this has cleared at 74p a bounce WILL occur to 80p and we may see 83p leading upto the results?.

[houseprices] 29/3/2007 11:26

Results Monday, very bullish statement coming. Looks like it will hold!

[3frog] 29/3/2007 11:17

80p territory, can we hold it this time?

[tipsheet] 29/3/2007 11:05

NO. I would like to see results first.
They should indeed come out first thing, which makes me think it will be tomorrow - But u never know!